Unknown

Dataset Information

TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription.


ABSTRACT:

Background

Cost, scalability, and durability represent major challenges to the implementation of intensive lifestyle treatments for obesity and diabetes. We previously reported pilot data from a 6-month intervention in which a self-insured manufacturing company partnered with a metabolic health clinic that utilizes therapeutic carbohydrate reduction (TCR), asynchronous monitoring, and a community-based approach to treat employees with metabolic disease. This manuscript presents weight loss and cost-savings from deprescription at the 12-month time point.

Methods

50 employees, mean BMI 43.2 ± 8.7 kg/m2, 64% with prediabetes or type 2 diabetes, were enrolled in the multimodal TOWARD telemedicine intervention, which includes: Text-based communications, Online interact

SUBMITTER: Buchanan L 

PROVIDER: S-EPMC11868080 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature